CAS 164025-44-9

3H-Pyrazolo[4,3-c]quinolin-3-one,2,5-dihydro-7-methoxy-2-(4-methoxyphenyl)-

Description:

3H-Pyrazolo[4,3-c]quinolin-3-one, 2,5-dihydro-7-methoxy-2-(4-methoxyphenyl)-, identified by its CAS number 164025-44-9, is a heterocyclic compound featuring a fused pyrazoloquinoline structure. This compound exhibits a range of characteristics typical of pyrazoloquinolines, including potential biological activity, which may be attributed to its unique molecular framework. The presence of methoxy groups enhances its lipophilicity and may influence its interaction with biological targets. The compound's structure suggests it could participate in various chemical reactions, including electrophilic substitutions and nucleophilic attacks, due to the reactivity of the quinoline and pyrazole moieties. Additionally, its potential applications in medicinal chemistry could be explored, particularly in the development of pharmaceuticals, given the known bioactivity of similar compounds. However, specific data on its solubility, stability, and toxicity would require further investigation through experimental studies. Overall, this compound represents a fascinating area of study within the realm of organic and medicinal chemistry.

Formula: C₁₈H₁₅N₃O₃

Synonyms:

• Pzii 029

2,5-Dihydro-7-methoxy-2-(4-methoxyphenyl)-3H-pyrazolo[4,3-c]quinolin-3-one

CAS: 164025-44-9

Formula: C₁₈H₁₅N₃O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 321.3300

Ref: IN-DA01ENJ3

PZ-II-029

CAS: 164025-44-9

PZ-II-029

Purity: ≥98%

Molecular weight: 321.33g/mol

Ref: 54-BUP12277

PZ-II-029

CAS: 164025-44-9

PZ-II-029 is an analog of a Chinese medicinal compound that has shown promising results in the treatment of cancer. This compound has been found to induce apoptosis (programmed cell death) and arrest the cell cycle in human cancer cells. PZ-II-029 is an inhibitor of a protein kinase, which plays a critical role in the growth and proliferation of tumor cells. This potent anticancer agent has been shown to be effective against various types of tumors and may have potential for use in combination with other cancer treatments. PZ-II-029 is derived from urine and is part of a new class of kinase inhibitors that hold great promise for the future of cancer therapy.

Formula: C₁₈H₁₅N₃O₃

Purity: Min. 95%

Molecular weight: 321.3 g/mol

Ref: 3D-PGA02544

PZ-II-029

CAS: 164025-44-9

PZ-II-029 is a modulator of α6β3γ2-selective GABAA channel.

Formula: C₁₈H₁₅N₃O₃

Purity: 99.79%

Color and Shape: Solid

Molecular weight: 321.33

Ref: TM-T28479